CFO TribuneCFO Voice ↗
More

Executive record

Charles Carter

Charles Carter holds the CFO seat at Ovid Therapeutics Inc. on the record, Chief Financial Officer, principal financial officer, principal accounting officer and secretary, effective July 6, 2026.

1 verified record · 1 company · current seat on the record: Ovid Therapeutics Inc.

Career line from the records

1

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-07-08TransitionOvid Therapeutics Inc.current seat

    Ovid Therapeutics Inc. CFO transition: Charles Carter to succeed Jeffrey Rona

    Named as the incoming officer, Chief Financial Officer, principal financial officer, principal accounting officer and secretary

    effective July 6, 2026 · 8-K filed July 8, 2026 · sec.gov, Item 5.02

Companies

1

Ovid Therapeutics Inc.OVID

Pharmaceutical Preparations

This page lists only verified filing records that name Charles Carter, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.